VBI

As newly-minted GenoFAB mulls commercial models for its GenoCAD DNA design web app, the company is trying to engage with its target market through pilot projects.

Researchers have developed a tool called RNA-Rocket to link RNA-seq and ChIP-seq software with data from pathogen-related sequence databases.

NEW YORK (GenomeWeb News) – US funding agencies may have awarded millions of dollars in duplicate grants, according to an analysis by Virginia Bioinformatics Institute researchers presented as a peer-reviewed comment

Virginia Tech's Virginia Bioinformatics Institute has established a Genomics Research Laboratory that will serve both internal researchers as well as outside groups needing sequencing and bioinformatics.

NEW YORK (GenomeWeb News) – An interdisciplinary team of Virginia Tech scientists have won a $1 million award from the National Science Foundation that they will use to optimize the processes and tools used for building custom DNA molecules and to train young researchers and students in DNA synth

Virginia Tech's bioinformatics institute wins $1 million grant from the NSF to develop a systems bio database for studying plant adaptability.

Scientists at VBI will use the USDA grant to study pathogens that cause soybean rot and are a costly menace to growers.

The Virginia Bioinformatics Institute is raising funds for a $30 million, roughly 50,000-square-foot building that would link the institute’s two existing buildings.

The Virginia Bioinformatics Institute at Virginia Tech has launched the VBI Industrial Affiliates Program, designed to develop new academic-industry partnerships in the institute's four research programs.

Pages

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.